Us Bancorp \De\ Acadia Pharmaceuticals Inc Transaction History

Us Bancorp \De\

$75.6 Billion
Q4 2024

A detailed history of Us Bancorp \De\ transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Us Bancorp \De\ holds 32,858 shares of ACAD stock, worth $576,986. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,858

Previous 32,934 0.23%

Holding current value

$576,986

Previous $506,000 18.97%

% of portfolio

0.0%

Previous 0.0%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 05, 2025	SELL	$14.29 - $18.76 $1,086 - $1,425	-76 Reduced 0.23%	32,858 $602,000
Q3 2024 Oct 28, 2024	BUY	$15.14 - $19.14 $475,789 - $601,493	31,426 Added 2083.95%	32,934 $506,000
Q2 2024 Aug 06, 2024	BUY	$14.62 - $18.42 $12,397 - $15,620	848 Added 128.48%	1,508 $24,000
Q1 2024 May 07, 2024	SELL	$17.79 - $30.86 $17 - $30	-1 Reduced 0.15%	660 $12,000
Q4 2023 Feb 09, 2024	SELL	$20.78 - $31.77 $893 - $1,366	-43 Reduced 6.11%	661 $20,000
Q3 2023 Nov 03, 2023	SELL	$20.84 - $33.47 $20 - $33	-1 Reduced 0.14%	704 $14,000
Q2 2023 Aug 09, 2023	SELL	$17.8 - $25.65 $10,769 - $15,518	-605 Reduced 46.18%	705 $16,000
Q1 2023 May 09, 2023	BUY	$16.32 - $20.92 $4,879 - $6,255	299 Added 29.57%	1,310 $24,000
Q4 2022 Feb 13, 2023	SELL	$14.2 - $18.63 $3,067 - $4,024	-216 Reduced 17.6%	1,011 $16,000
Q3 2022 Oct 27, 2022	SELL	$14.11 - $18.27 $4,430 - $5,736	-314 Reduced 20.38%	1,227 $20,000
Q2 2022 Aug 01, 2022	SELL	$13.01 - $27.22 $19,267 - $40,312	-1,481 Reduced 49.01%	1,541 $22,000
Q1 2022 May 11, 2022	BUY	$20.94 - $27.5 $12,040 - $15,812	575 Added 23.5%	3,022 $73,000
Q4 2021 Feb 11, 2022	SELL	$16.79 - $27.09 $28,391 - $45,809	-1,691 Reduced 40.87%	2,447 $57,000
Q3 2021 Nov 10, 2021	SELL	$15.78 - $24.77 $6,548 - $10,279	-415 Reduced 9.11%	4,138 $69,000
Q2 2021 Aug 05, 2021	BUY	$19.4 - $27.42 $11,038 - $15,601	569 Added 14.28%	4,553 $111,000
Q1 2021 Apr 28, 2021	BUY	$25.02 - $54.99 $4,528 - $9,953	181 Added 4.76%	3,984 $103,000
Q4 2020 Feb 04, 2021	SELL	$41.04 - $56.79 $43,133 - $59,686	-1,051 Reduced 21.65%	3,803 $202,000
Q3 2020 Nov 10, 2020	BUY	$36.42 - $57.0 $1,821 - $2,850	50 Added 1.04%	4,854 $200,000
Q2 2020 Aug 07, 2020	SELL	$39.26 - $52.73 $28,816 - $38,703	-734 Reduced 13.25%	4,804 $233,000
Q1 2020 May 13, 2020	BUY	$31.65 - $46.87 $57,539 - $85,209	1,818 Added 48.87%	5,538 $234,000
Q4 2019 Feb 04, 2020	BUY	$36.21 - $51.4 $85,962 - $122,023	2,374 Added 176.37%	3,720 $159,000
Q3 2019 Nov 08, 2019	BUY	$22.22 - $44.01 $19,286 - $38,200	868 Added 181.59%	1,346 $48,000
Q2 2019 Aug 13, 2019	SELL	$23.32 - $28.12 $13,852 - $16,703	-594 Reduced 55.41%	478 $12,000
Q1 2019 May 08, 2019	SELL	$16.17 - $27.38 $8,602 - $14,566	-532 Reduced 33.17%	1,072 $28,000
Q4 2018 Feb 13, 2019	SELL	$14.32 - $22.92 $887 - $1,421	-62 Reduced 3.72%	1,604 $26,000
Q3 2018 Nov 01, 2018	BUY	$13.03 - $21.81 $20,717 - $34,677	1,590 Added 2092.11%	1,666 $35,000
Q2 2018 Aug 08, 2018	SELL	$15.07 - $22.34 $6,012 - $8,913	-399 Reduced 84.0%	76 $1,000
Q1 2018 May 08, 2018	SELL	$22.47 - $32.33 $22,357 - $32,168	-995 Reduced 67.69%	475 $11,000
Q4 2017 Feb 02, 2018	SELL	$26.84 - $39.14 $5,985 - $8,728	-223 Reduced 13.17%	1,470 $44,000
Q3 2017 Nov 13, 2017	BUY	$29.49 - $38.37 $49,926 - $64,960	1,693	1,693 $63,000

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.84B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

News

Stay updated on Us Bancorp \De\ with notifications on news.

Account